Adult Stem Cells Show Positive Results in a Pre-Clinical Study of Ischemic Stroke
The biotech company Pluristem Therapeutics Inc. has found improvement in an animal model of ischemic stroke with the use of a therapeutic product developed from mesenchymal stromal cells.